Literature DB >> 20067875

Proniosomes as drug carriers.

V Sankar1, K Ruckmani, S Durga, S Jailani.   

Abstract

Approaches to stabilize niosomal drug delivery system without affecting its properties of merits have resulted in the development of the promising drug carrier, proniosomes. Proniosomes is dry formulation using suitable carrier coated with non ionic surfactants and can be converted into niosomes immediately before use by hydration. These proniosome-derived niosomes are as good as or even better than conventional niosomes. The focus of this review is to bring out different aspects related to proniosomes preparation, characterization, entrapment efficiency, in vitro drug release, applications and merits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067875

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  7 in total

1.  Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.

Authors:  Tamer M Shehata; Marwa H Abdallah; Mahmoud Mokhtar Ibrahim
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

Review 2.  Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.

Authors:  Kevin Ita; Sharon Ashong
Journal:  AAPS PharmSciTech       Date:  2020-01-06       Impact factor: 3.246

3.  Intranasal delivery of Clozapine using nanoemulsion-based in-situ gels: An approach for bioavailability enhancement.

Authors:  Nourhan A Abdulla; Gehan F Balata; Hanaa A El-Ghamry; Eman Gomaa
Journal:  Saudi Pharm J       Date:  2021-11-15       Impact factor: 4.330

Review 4.  Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.

Authors:  Eliana B Souto; Joana F Fangueiro; Ana R Fernandes; Amanda Cano; Elena Sanchez-Lopez; Maria L Garcia; Patrícia Severino; Maria O Paganelli; Marco V Chaud; Amélia M Silva
Journal:  Heliyon       Date:  2022-02-11

5.  Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.

Authors:  Eglal I Amer; Iman Fathy Abou-El-Naga; Laila M Boulos; Heba S Ramadan; Salwa S Younis
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

6.  Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

Authors:  Dinesh Kumar; Deepak Sharma; Gurmeet Singh; Mankaran Singh; Mahendra Singh Rathore
Journal:  ISRN Pharm       Date:  2012-07-19

Review 7.  A review on proniosomal drug delivery system for targeted drug action.

Authors:  G V Radha; T Sudha Rani; B Sarvani
Journal:  J Basic Clin Pharm       Date:  2013-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.